Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.42p
   
  • Change Today:
    -0.010p
  • 52 Week High: 1.15
  • 52 Week Low: 0.39
  • Currency: UK Pounds
  • Shares Issued: 203.21m
  • Volume: 2,449,924
  • Market Cap: £0.84m
  • RiskGrade: 504
  • Beta: 0.02

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -123.5% -89.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.6 2.4
Pr/Book 3.0  
Latest F'cast
Revenue -9.1% 33.5%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%
30-Jun-24 0.54 (0.67) (0.45)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 0.73 (0.65) (0.23)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Physiomics Company Announcements

Contract Award 01-Jul-2025 07:00 RNS
New Head of Biometrics and Two Contracts Awarded 16-Jun-2025 07:00 RNS
Physiomics Awarded Contract Extension 29-May-2025 07:00 RNS

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.42p
Change Today -0.010p
% Change -2.35 %
52 Week High 1.15
52 Week Low 0.39
Volume 2,449,924
Shares Issued 203.21m
Market Cap £0.84m
Beta 0.02
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.51% below the market average21.51% below the market average21.51% below the market average21.51% below the market average21.51% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
Price Trend
81.18% below the market average81.18% below the market average81.18% below the market average81.18% below the market average81.18% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Income Not Available
Growth
54.21% below the market average54.21% below the market average54.21% below the market average54.21% below the market average54.21% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

Physiomics Dividends

No dividends found

Trades for 04-Jul-2025

Time Volume / Share Price
16:19 275,000 @ 0.42p
15:57 500,000 @ 0.42p
15:32 1,000,000 @ 0.40p
12:54 33,798 @ 0.43p
11:58 11,718 @ 0.43p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page